BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massari S, Desantis J, Nizi MG, Cecchetti V, Tabarrini O. Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions. ACS Infect Dis 2021;7:1332-50. [PMID: 33044059 DOI: 10.1021/acsinfecdis.0c00552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Rostaminia S, Aghaei SS, Farahmand B, Nazari R, Ghaemi A. In-Silico Design of a Multi‑epitope Construct Against Influenza A Based on Nucleoprotein Gene. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10418-w] [Reference Citation Analysis]
2 Nizi MG, Persoons L, Corona A, Felicetti T, Cernicchi G, Massari S, Manfroni G, Vangeel L, Barreca ML, Esposito F, Jochmans D, Milia J, Cecchetti V, Schols D, Neyts J, Tramontano E, Sabatini S, De Jonghe S, Tabarrini O. Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity. ACS Med Chem Lett 2022;13:855-64. [PMID: 35571875 DOI: 10.1021/acsmedchemlett.2c00123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ianevski A, Yao R, Simonsen RM, Myhre V, Ravlo E, Kaynova GD, Zusinaite E, White JM, Polyak SJ, Oksenych V, Windisch MP, Pan Q, Lastauskienė E, Vitkauskienė A, Matukevičius A, Tenson T, Bjørås M, Kainov DE. Mono- and combinational drug therapies for global viral pandemic preparedness. iScience 2022;25:104112. [DOI: 10.1016/j.isci.2022.104112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hou L, Zhang Y, Ju H, Cherukupalli S, Jia R, Zhang J, Huang B, Loregian A, Liu X, Zhan P. Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins. Acta Pharmaceutica Sinica B 2022;12:1805-24. [DOI: 10.1016/j.apsb.2021.11.018] [Reference Citation Analysis]
5 Chen W, Shao J, Ying Z, Du Y, Yu Y. Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit. Drug Discov Today 2022:S1359-6446(22)00085-X. [PMID: 35247593 DOI: 10.1016/j.drudis.2022.02.024] [Reference Citation Analysis]
6 Agamennone M, Superti F. Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies. Pharmaceuticals 2022;15:301. [DOI: 10.3390/ph15030301] [Reference Citation Analysis]
7 Felicetti T, Massari S. Protein-protein interactions by influenza polymerase subunits as drug targets. Future Med Chem 2021. [PMID: 34730024 DOI: 10.4155/fmc-2021-0259] [Reference Citation Analysis]
8 Dunsing V, Petrich A, Chiantia S. Multicolor fluorescence fluctuation spectroscopy in living cells via spectral detection. Elife 2021;10:e69687. [PMID: 34494547 DOI: 10.7554/eLife.69687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Blaszczak E, Lazarewicz N, Sudevan A, Wysocki R, Rabut G. Protein-fragment complementation assays for large-scale analysis of protein-protein interactions. Biochem Soc Trans 2021;49:1337-48. [PMID: 34156434 DOI: 10.1042/BST20201058] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Yin H, Jiang N, Shi W, Chi X, Liu S, Chen JL, Wang S. Development and Effects of Influenza Antiviral Drugs. Molecules 2021;26:810. [PMID: 33557246 DOI: 10.3390/molecules26040810] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
11 Massari S, Bertagnin C, Pismataro MC, Donnadio A, Nannetti G, Felicetti T, Di Bona S, Nizi MG, Tensi L, Manfroni G, Loza MI, Sabatini S, Cecchetti V, Brea J, Goracci L, Loregian A, Tabarrini O. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase. Eur J Med Chem 2021;209:112944. [PMID: 33328103 DOI: 10.1016/j.ejmech.2020.112944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]